WSI “Easy Medibot, world’s first robotic uterine lifter to be commercialized within the year”


WSI



WSI
299170
|
KOSDAQ

Securities information






Current price
1,679


Compared to the previous day
369


fluctuation rate
+28.17%


trading volume
2,694,723


Jeonilga
1,310



As of 2025.01.06 09:32

Related articles

WSI establishes catheter delivery system at over 50 major hospitals across the country… “New business smooth sailing” WSI “Intro Biopharma plans to launch new generic product with improved formulation… Expecting additional sales of KRW 10 billion” WSI, 3Q sales of KRW 12.9 billion… “Realization of high external growth”


close


announced on the 6th that it plans to commercialize ‘U-BOT’, the world’s first robotic uterine lifter developed by its subsidiary Easy Medibot, this year. Currently, prototype development is completed and the product is approved by the Ministry of Food and Drug Safety, and then full-scale domestic sales and exports are scheduled to begin.

Ubot is an assist robot for obstetrics and gynecology laparoscopic surgery. By automating the uterine lift operation, surgery time can be shortened and human errors can be reduced.

Even in surgeries with expensive robotic equipment currently costing 2 to 3 billion won, uterine lifting is a high-intensity task that requires medical staff to perform in a sitting position for long periods of time. Currently, most of the surgeries are performed by residents, but there are cases where surgeries are reduced or delayed due to a shortage of obstetrics and gynecology residents. As the same problem is serious even in advanced medical countries, Ubot is attracting attention as a technology to solve the problem of medical manpower shortage.

The main indications for U-BOT include ▲laparoscopic hysterectomy ▲myomectomy ▲ovarian cancer surgery ▲uterine artery embolization. Since the problems of the existing method have been improved with automatic robot control technology, it is expected to expand into various surgical fields.

Reporter Yoo Hyeon-seok guspower@asiae.co.kr

<ⓒ투자가를 위한 경제콘텐츠 플랫폼, 아시아경제(www.asiae.co.kr) 무단전재 배포금지>

Source: www.asiae.co.kr